Zentalis Pharmaceuticals shares owned by Barclays
Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Zentalis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Zentalis Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Zentalis Pharmaceuticals by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $355k | 117k | 3.02 |
| 2024-09-30 | $277k | 75k | 3.67 |
| 2024-06-30 | $261k | 64k | 4.10 |
| 2024-03-31 | $1.0M | 66k | 15.76 |
| 2023-12-31 | $3.3M | 220k | 15.15 |
| 2023-09-30 | $2.2M | 111k | 20.06 |
| 2023-06-30 | $6.0M | 212k | 28.21 |
| 2023-03-31 | $1.5M | 90k | 17.19 |
| 2022-12-31 | $2.6M | 128k | 20.14 |
| 2022-09-30 | $2.5M | 117k | 21.66 |
| 2022-06-30 | $96k | 3.4k | 27.99 |
| 2022-03-31 | $316k | 6.9k | 46.13 |